Edition:
India

Knight Therapeutics Inc (GUD.TO)

GUD.TO on Toronto Stock Exchange

6.80CAD
7 Aug 2020
Change (% chg)

$0.00 (+0.00%)
Prev Close
$6.80
Open
$6.73
Day's High
$6.85
Day's Low
$6.73
Volume
133,228
Avg. Vol
344,676
52-wk High
$8.88
52-wk Low
$4.73

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2020 Mar '20 45.84 -0.013
FY 2019 Dec '19 37.27 -0.049
Sep '19 4.03 -0.021
Jun '19 3.20 0.132
Mar '19 2.96 0.036
FY 2018 Dec '18 3.89 0.002
Sep '18 3.22 0.090
Jun '18 2.24 0.028
Mar '18 3.15 0.048
 
*Note: Units in Millions ofCanadian Dollars
**Note: Units in Canadian Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-20 4 51.29 56.10 44.40 5.40
Quarter Ending Dec-20 4 61.52 69.40 54.90 5.50
Year Ending Dec-20 7 214.53 225.60 189.10 26.34
Year Ending Dec-21 6 239.96 259.95 201.80 65.22
Earnings (per share)
Quarter Ending Sep-20 5 -0.00 0.07 -0.06 0.04
Quarter Ending Dec-20 4 -0.00 0.01 -0.01 0.03
Year Ending Dec-20 6 0.05 0.25 -0.09 0.15
Year Ending Dec-21 6 0.11 0.33 0.01 0.33
Sales and Profit Figures in Canadian Dollar (CAD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 138.63 34.34 38.19
P/E High - Last 5 Yrs. 73.17 43.41 46.52
P/E Low - Last 5 Yrs. 21.81 25.28 25.22
Beta 0.78 0.96 0.94
Price to Sales (TTM) 9.86 4.47 7.83
Price to Book (MRQ) 1.16 4.25 4.60
Price to Tangible Book (MRQ) 1.66 5.00 5.67
Price to Cash Flow (TTM) 59.85 21.06 28.03
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 1.54 1.45
Dividend Yield - 5 Year Avg -- 0.90 0.90
Dividend 5 Year Growth Rate -- 3.91 4.69
Payout Ratio(TTM) 0.00 50.04 47.50

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 1,450.71 10.05 8.01
Sales (TTM) vs TTM 1 Yr. Ago 634.38 13.83 12.97
Sales - 5 Yr. Growth Rate 164.69 5.89 6.16
EPS (MRQ) vs Qtr. 1 Yr. Ago -134.93 85.04 64.19
EPS (TTM) vs TTM 1 Yr. Ago -68.55 -- --
EPS - 5 Yr. Growth Rate -45.71 8.46 8.71
Capital Spending - 5 Yr. Growth Rate 111.49 13.06 12.96

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 1.86 2.36 2.39
Current Ratio (MRQ) 2.06 3.21 3.25
LT Debt to Equity (MRQ) 1.11 12.75 15.14
Total Debt to Equity (MRQ) 8.25 18.68 21.31
Interest Coverage (TTM) -- 11.53 14.43

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 49.26 54.67 54.43
Gross Margin - 5 Yr. Avg. 65.16 54.60 54.16
EBITD Margin (TTM) 2.93 -- --
EBITD - 5 Yr. Avg -26.61 19.08 12.49
Operating Margin (TTM) -23.77 14.65 -0.77
Operating Margin - 5 Yr. Avg. 35.89 14.80 7.59
Pre-Tax Margin (TTM) 6.12 15.03 -1.43
Pre-Tax Margin - 5 Yr. Avg. 177.23 15.08 7.77
Net Profit Margin (TTM) 3.73 11.34 -5.10
Net Profit Margin - 5 Yr. Avg. 148.31 11.41 4.21
Effective Tax Rate (TTM) 39.10 17.32 18.20
Effective Tax Rate - 5 Yr. Avg. 16.31 22.17 22.25

Efficiency

  Company industry sector
Revenue/Employee (TTM) 125,652 980,761,022 852,479,176
Net Income/Employee (TTM) 4,683 112,525,796 97,707,050
Receivable Turnover (TTM) 2.23 5.55 6.40
Inventory Turnover (TTM) 1.26 2.57 3.38
Asset Turnover (TTM) 0.08 0.82 0.80

Management Effectiveness

  Company industry sector
Return on Assets (TTM) 0.29 10.53 9.91
Return on Assets - 5 Yr. Avg. 2.44 11.11 10.64
Return on Investment (TTM) 0.36 13.16 12.53
Return on Investment - 5 Yr. Avg. 2.60 13.90 13.32
Return on Equity (TTM) 0.84 14.88 14.34
Return on Equity - 5 Yr. Avg. 2.53 16.69 16.02
  1 Year 3 Year 5 Year
Sales % 279.69 99.92 164.69
EPS (TTM) % -38.36 -12.20 -45.71
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Knight Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -2.16 -7.07 35 73
13 Week -11.34 -19.80 18 47
26 Week -11.80 -5.88 34 76
52 Week -8.60 -9.38 40 75
YTD -10.29 -7.48 36 74
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 23.81%
# of Holders: 67
Total Shares Held: 31,172,730
3 Mo. Net Change: 3,016,294
# New Positions: 4
# Closed Positions: 1
# Increased Positions: 16
# Reduced Positions: 7
# Net Buyers: 9
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.